Skip to main content

Table 5 Relationship between serum tumor markers and pathological factors

From: CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy

   N stage P value ypTNM P value VOLI P value
   N- N+   I-II III   +  
pre-CA199 80 125 0.009 93 112 0.050 156 49 0.400
+ 15 54   22 47   49 20  
pre-CA125 62 74 0.000 69 67 0.001 102 34 0.116
+ 6 46   12 40   33 19  
pre-CA724 49 92 0.039 63 78 0.007 110 31 0.082
+ 18 65   22 61   56 27  
post-CA199 81 133 0.003 100 114 0.003 159 55 0.559
+ 3 26   5 24   23 6  
post-CA125 44 44 0.001 49 39 0.014 65 23 0.854
+ 22 62   31 53   61 23  
post-CA724 45 69 0.022 53 61 0.098 91 23 0.019
+ 17 56   25 48   47 26  
diff-CA199 34 62 0.833 41 55 0.969 70 26 0.650
+ 46 89   58 77   102 33  
diff-CA125 23 51 0.152 32 42 0.567 52 22 0.754
+ 31 42   35 38   53 20  
diff-CA724 24 50 0.669 26 48 0.275 50 24 0.223
+ 27 65   40 52   70 22  
  1. VOLI Vascular or lymphatic invasion